Primary Peritoneal Cavity Cancer

Showing 26 - 50 of 126

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colon Cancer, Pancreatic Cancer, Perioperative/Postoperative Complications Trial in Winston-Salem (wound care management)

Completed
  • Colon Cancer
  • +4 more
  • wound care management
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018

Carcinoma of the Appendix, Primary Peritoneal Cavity Cancer Trial in Winston-Salem, Pittsburgh, Houston (drug, procedure, other)

Completed
  • Carcinoma of the Appendix
  • Primary Peritoneal Cavity Cancer
  • mitomycin C
  • +4 more
  • Winston-Salem, North Carolina
  • +2 more
Jun 29, 2018

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Canada, United States (topotecan HCl)

Terminated
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • topotecan hydrochloride
  • Birmingham, Alabama
  • +73 more
Apr 11, 2018

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New Haven (docetaxel, idronoxil, )

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • New Haven, Connecticut
    Yale Cancer Center
Jan 12, 2018

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (motesanib diphosphate)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • motesanib diphosphate
  • Burbank, California
  • +18 more
Dec 12, 2017

Anal Cancer, Carcinoma of the Appendix, Colorectal Cancer Trial in United States (palonosetron HCl, )

Terminated
  • Anal Cancer
  • +11 more
  • palonosetron hydrochloride
  • placebo
  • Scottsdale, Arizona
  • +68 more
Oct 20, 2017

Colorectal Cancer, Primary Peritoneal Cavity Cancer Trial in France (fluorouracil, leucovorin calcium, oxaliplatin)

Completed
  • Colorectal Cancer
  • Primary Peritoneal Cavity Cancer
  • Angers, France
  • +19 more
Aug 29, 2016

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Charlottesville (biological, drug, procedure)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine
  • +4 more
  • Charlottesville, Virginia
    University of Virginia Cancer Center
Aug 11, 2016

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New Haven, Carlton (cisplatin, paclitaxel,

Completed
  • Fallopian Tube Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jul 13, 2016

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Hamilton, London, Toronto

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Hamilton, Ontario, Canada
  • +2 more
Jun 21, 2016

Leukemia, Lung Cancer, Malignant Mesothelioma Trial in New York (biological, genetic, other)

Completed
  • Leukemia
  • +4 more
  • WT-1 analog peptide vaccine
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 2, 2016

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (sorafenib tosylate, immunoenzyme

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • sorafenib tosylate
  • +4 more
  • New York, New York
    Memorial Sloan - Kettering Cancer Center
Feb 1, 2016

Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer Trial (recombinant adenovirus-p53 SCH-58500)

Completed
  • Fallopian Tube Cancer
  • +3 more
  • recombinant adenovirus-p53 SCH-58500
  • (no location specified)
Feb 3, 2016

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Germany (carboplatin, gemcitabine HCl,

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Berlin, Germany
  • +17 more
Dec 22, 2015

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Worldwide (carboplatin, cisplatin, conventional

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Buenos Aires, Argentina
  • +64 more
Aug 4, 2015

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Canada (7-hydroxystaurosporine, topotecan HCl)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Hamilton, Ontario, Canada
  • +3 more
Jul 22, 2015

Cervical Cancer, Fallopian Tube Cancer, Head Neck Cancer Trial run by the NCI (SS1(dsFv)-PE38 immunotoxin)

Completed
  • Cervical Cancer
  • +7 more
  • SS1(dsFv)-PE38 immunotoxin
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 29, 2015

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial run by the NCI (imatinib mesylate)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • imatinib mesylate
  • Bethesda, Maryland
  • +1 more
Apr 29, 2015

Cervical Cancer, Fallopian Tube Cancer, Head Neck Cancer Trial in Bethesda, Winston-Salem (SS1(dsFv)-PE38 immunotoxin)

Completed
  • Cervical Cancer
  • +7 more
  • SS1(dsFv)-PE38 immunotoxin
  • Bethesda, Maryland
  • +1 more
Apr 29, 2015

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Charlottesville (incomplete Freund's adjuvant, ovarian cancer peptide

Completed
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • incomplete Freund's adjuvant
  • +4 more
  • Charlottesville, Virginia
    University of Virginia Cancer Center
May 19, 2014

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer Trial in Rochester

Completed
  • Primary Peritoneal Cavity Cancer
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
May 2, 2014

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Worldwide (cetuximab, carboplatin)

Completed
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • Birmingham, Alabama
  • +75 more
Feb 12, 2014

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (pemetrexed disodium)

Completed
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • pemetrexed disodium
  • Hinsdale, Illinois
  • +34 more
Feb 12, 2014

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (biological, drug, procedure)

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • filgrastim
  • +6 more
  • New York, New York
    Herbert Irving Comprehensive Cancer Center
Jan 3, 2014